SYNACT PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.8 SEK | -5.09% |
|
-3.41% | -22.99% |
| 04-23 | Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting | CI |
| 03-20 | Sweden's SynAct Pharma Names New CEO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 26.66M | - | - | - | - | - | |
| 54.64B | - | |||||
| 39.92B | ||||||
| 38.82B | ||||||
| 26.86B | ||||||
| 26.22B |
- Stock Market
- Equities
- SYNACT Stock
- Charts SynAct Pharma AB
- Sector Chart
